Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen Raises $8.2M in Venture Capital

NEW YORK, Dec. 2 (GenomeWeb News) - NimbleGen Systems has raised $8.2 million during its latest round of private-equity financing, the company said today.


The company will use the new funding to finance growth and expansion, NimbleGen said. The company focuses on high-definition genomics by combining its microarray platform with its gene expression products, ChIP-chip, CGH, and comparative genome sequencing.


Cargill Ventures and Skyline Ventures led the private venture financing round and all of the company's existing venture capital and institutional investors participated.


NimbleGen has raised $50 million since its inception in 1999.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.